Two entities exit Sansera Engg; sell 11.66% stake for Rs 750 crore
Client Ebene and CVCIGP II Employee Ebene were the two entities who offloaded their shares in Bengaluru-based Sansera Engineering through separate block deals on the National Stock Exchange (NSE).
Two entities on Wednesday exited Sansera Engineering by selling their entire 11.66 per cent stake in the auto components manufacturer for a combined value of Rs 750 crore through open market transactions.
Client Ebene and CVCIGP II Employee Ebene were the two entities who offloaded their shares in Bengaluru-based Sansera Engineering through separate block deals on the National Stock Exchange (NSE).
A total of 62.53 lakh shares, representing an 11.66 per cent stake, were sold by both entities.
As per the data on the NSE, Client Ebene Ltd sold 50.30 lakh shares of Sansera Engineering, and CVCIGP II Employee Ebene offloaded 12.23 lakh shares, amounting to a 9.38 per cent and 2.28 per cent stake, respectively, in the company.
The shares were disposed of at an average price of Rs 1,200 apiece, taking the combined transaction value to Rs 750.39 crore.
A clutch of domestic mutual funds, insurance companies and foreign investors have bought shares of the auto components maker.
SBI Mutual Fund (MF), Axis MF, Bandhan MF, DSP MF, HDFC Standard Life Insurance, ICICI Prudential Life Insurance, Morgan Stanley Asia Singapore, Societe Generale, Custody Bank of Japan Ltd, Amundi Funds New Silk Road were among the buyers of the stake in Sansera Engineering.
As of March 2024, Client Ebene Ltd held a 9.38 per cent stake in Sansera Engineering, while CVCIGP II Employee Ebene owned a 2.28 per cent stake in the auto components manufacturer.
On Wednesday, shares of Sansera Engineering jumped 5.14 per cent to close at Rs 1,274 apiece on the NSE.
In June 2023, Client Ebene and CVCIGP II Employee Ebene pared a 14 per cent stake in Sansera Engineering for Rs 622 crore.
In a separate block deal on the NSE, Orbimed Asia III Mauritius divested its entire 9.88 per cent stake in Advanced Enzyme Technologies for Rs 425 crore through an open market transaction.
Orbimed Asia III Mauritius sold 1,10,53,245 shares, amounting to a 9.88 per cent stake in Advanced Enzyme Technologies, as per the data on the NSE.
The shares were offloaded at an average price of Rs 385 apiece, taking the deal size to Rs 425.55 crore.
These shares were acquired by Motilal Oswal Financial Services at the same price.
The scrip of Advanced Enzyme Technologies slipped 0.29 per cent to settle at Rs 380.70 per piece on the NSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
08:51 PM IST